| 1987 |
The hst (FGF4) gene encodes a 206 amino acid open reading frame that is sufficient for transforming activity when expressed in NIH3T3 cells via an SV40 promoter-containing vector. |
cDNA cloning, expression vector transfection, NIH3T3 transformation assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
2953031
|
| 1991 |
FGF4 (K-fgf/hst) transforms cells through an autocrine mechanism that requires secretion and extracellular receptor activation at the cell surface; deletion of the signal peptide or retention of the protein in the ER (KDEL motif) abolishes transforming activity, and anti-FGF4 neutralizing antibodies reverse the transformed phenotype. |
Signal peptide deletion mutants, KDEL retention mutants, NIH3T3 focus formation assay, neutralizing antibody treatment, soft-agar and serum-free growth assays |
Molecular and cellular biology |
High |
1990270
|
| 1991 |
Cell transformation by kFGF requires secretion but not glycosylation; cytoplasmic or ER-retained kFGF mutants fail to transform NIH3T3 cells, and suramin reverses transformation by both glycosylated and unglycosylated secreted forms. |
Glycosylation site mutagenesis, KDEL retention mutant, NIH3T3 transformation assay, suramin inhibition |
The Journal of cell biology |
High |
1655808
|
| 1991 |
The kFGF/FGF4 gene enhancer contains an octamer-binding sequence that binds Oct1 and Oct4 (but not Oct1 alone after differentiation), indicating that Oct4 positively regulates FGF4 transcription in undifferentiated embryonal carcinoma and embryonic stem cells. |
CAT reporter assays, electrophoretic mobility shift assay (EMSA), transfection into EC/ES cells |
Mechanisms of development |
Medium |
1723621
|
| 1992 |
FGF4 signaling for myoblast repression requires heparan sulfate proteoglycans (HSPG); chlorate-mediated inhibition of glycosaminoglycan sulfation abrogates FGF4 biological activity, which is restored by heparin or sodium sulfate co-addition. |
Chlorate treatment of MM14 myoblasts, heparitinase treatment, FGF binding assay, differentiation assay |
The Journal of cell biology |
High |
1379245
|
| 1994 |
FGF4 protein expressed in the enamel knot stimulates proliferation of both dental epithelial and mesenchymal cells in vitro, while the enamel knot cells themselves do not divide, supporting a paracrine growth-stimulating role during tooth cusp morphogenesis. |
In situ hybridization, in vitro FGF4 protein addition to isolated dental tissues, cell proliferation assessment |
The International journal of developmental biology |
Medium |
7848830
|
| 1994 |
FGF4 promotes differentiation of parietal endoderm from isolated inner cell mass (ICM) cells and increases secretion of 92 kDa gelatinase and tissue plasminogen activator; FGFR-3 and FGFR-4 receptors are expressed on all blastocyst cells. |
Immunosurgery ICM isolation, recombinant FGF4 culture, morphological analysis, zymography, receptor expression by Northern blot |
Development (Cambridge, England) |
Medium |
7925026
|
| 1994 |
FGF4 angiogenic activity is demonstrated in vivo by chick chorioallantoic membrane assay and rat cornea assay using recombinant hst-1 protein produced in E. coli. |
Recombinant protein production in E. coli, CAM assay, rat cornea assay, nude mouse tumor vascularization |
Cancer letters |
Medium |
7520355
|
| 1994 |
The FGF4 gene is positively regulated by an upstream NF-Y binding site (sequence CTGATTGGCA) in its promoter that cooperates with the downstream octamer enhancer in F9 embryonal carcinoma cells. |
CAT reporter assays, deletion/mutation analysis, EMSA, methylation interference, anti-NF-Y antibody supershift |
The Journal of biological chemistry |
Medium |
7929190
|
| 1994 |
Adenovirus-mediated HST-1/FGF4 gene transfer in vivo causes a twofold increase in peripheral platelet count and increased megakaryocyte numbers in bone marrow and spleen, demonstrating an in vivo thrombopoietic role. |
Adenovirus-mediated gene transfer in nude mice, platelet counting, histology of bone marrow and spleen, recombinant protein injection |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
7809043
|
| 1995 |
FGF-4 gene expression requires synergistic action of Sox2 and Oct-3 on adjacent binding sites in the downstream enhancer; Sox2 forms a ternary complex with Oct-3 (but not Oct-1) on FGF-4 enhancer DNA, and only the Sox2/Oct-3 complex drives transcriptional activation. |
cDNA cloning of Sox2 from F9 cells, CAT reporter assays, EMSA, ternary complex formation experiments |
Genes & development |
High |
7590241
|
| 1995 |
Homozygous disruption of Fgf4 by gene targeting causes early postimplantation lethality with severely impaired inner cell mass proliferation; this ICM proliferation defect is rescued by exogenous FGF4 protein in vitro, demonstrating an essential mitogenic role for FGF4 in early embryogenesis. |
Gene targeting (knockout), embryo culture, exogenous FGF4 protein rescue experiment |
Science (New York, N.Y.) |
High |
7809630
|
| 1995 |
HST-1/FGF4 antisense oligodeoxynucleotides block mouse limb bud outgrowth in an organ culture system, while sense and scrambled ODNs have no effect, establishing a required role for FGF4 in limb development. |
Antisense oligodeoxynucleotide treatment, limb bud organ culture, morphological assessment |
The Journal of cell biology |
Medium |
7642715
|
| 1995 |
Adenovirus-mediated FGF4 gene transfer effectively prevents chemotherapy- and irradiation-induced thrombocytopenia in mice by stimulating megakaryocyte production, with sustained serum FGF4 elevation for ≥30 days. |
Adenoviral gene transfer, thrombocytopenic mouse model (chemotherapy/irradiation), platelet counting, bone marrow histology |
The Journal of clinical investigation |
Medium |
7635948
|
| 1998 |
FGF4 produced by the AER promotes trophoblast stem cell proliferation; culture of mouse blastocysts or early postimplantation trophoblasts with FGF4 allows isolation of permanent trophoblast stem cell lines that differentiate in vitro upon FGF4 withdrawal. |
Blastocyst culture with recombinant FGF4, trophoblast stem cell line derivation, in vitro differentiation, in vivo chimera analysis |
Science (New York, N.Y.) |
High |
9851926
|
| 1998 |
FGF4 antagonizes BMP-induced apoptosis and BMP-induced chondrogenesis in chick limb buds; FGF4 prevents BMP-mediated mesenchyme apoptosis and nullifies BMP4-induced ectopic chondrogenesis when co-applied. |
Bead implantation into chick limb buds, apoptosis assessment, chondrocyte condensation analysis |
Mechanisms of development |
Medium |
9507096
|
| 1999 |
FGF4 in the AER is maintained by a SHH/FGF4 feedback loop: SHH signaling in the posterior mesenchyme induces Gremlin (a BMP antagonist) which relays the signal to induce Fgf4 expression in the AER; grafting Gremlin-expressing cells into limb deformity mutant limb buds rescues Fgf4 expression. |
Mouse mutant analysis (Shh-null, limb deformity mutants), Gremlin cell grafting rescue experiment, in situ hybridization |
Nature |
High |
10524628
|
| 1999 |
FGF4 provides a vertical signal (from notochord) that induces En1 expression in the midbrain neural plate; exogenous FGF4 mimics the notochord requirement for En1 induction in neural plate explants in vitro. |
Avian embryo tissue recombination, notochord ablation, FGF4 protein addition to neural plate explants in vitro |
Development (Cambridge, England) |
Medium |
9927596
|
| 2000 |
Conditional inactivation of Fgf4 in the mouse AER using Cre/loxP results in normal limb development with normal Shh, Bmp2, Fgf8, and Fgf10 expression, demonstrating that FGF4 alone is not essential for AER-mediated limb patterning and that the FGF4-SHH feedback loop is not required. |
Conditional knockout (Cre/loxP), limb morphology analysis, in situ hybridization for target genes |
Development (Cambridge, England) |
High |
10662638
|
| 2000 |
Conditional inactivation of Fgf4 in the mouse AER does not impair Shh expression or limb formation, but Shh is required for maintenance of Fgf9 and Fgf17 (but not Fgf8) in the AER; combined activities of multiple AER-FGFs function in the positive feedback loop with Shh. |
Conditional knockout (Cre/loxP), double mutant analysis, in situ hybridization |
Nature genetics |
High |
10802662
|
| 2001 |
Misexpression of Fgf-4 in the chick limb inhibits myogenesis by downregulating the FGF receptor Frek in muscle progenitors, leading to decreased myoblast proliferation and inhibition of terminal differentiation. |
Replication-competent retrovirus (RCAS) overexpression in chick limb, quail-chick transplantation cell tracking, in situ hybridization for muscle markers |
Developmental biology |
Medium |
11319857
|
| 2002 |
FGF4 is a direct transcriptional target of LEF1/Wnt signaling; LEF1 binds the Fgf4 promoter, Fgf4 is absent in Lef1-null tooth rudiments, and FGF4-soaked beads fully rescue the developmental arrest of Lef1-/- tooth germs. FGF4 then induces Fgf3 in dental mesenchyme and both epithelial and mesenchymal FGFs induce Shh. |
Lef1 knockout analysis, chromatin immunoprecipitation/reporter assay for LEF1 binding to Fgf4, bead rescue experiment in Lef1-/- tooth organ culture |
Genes & development |
High |
12502739
|
| 2002 |
Fgf4 expressed in limb muscle is required for maintenance of tendon markers scleraxis and tenascin; exogenous FGF4 restores scleraxis and tenascin expression in muscleless and aneural limbs, but does not restore Fgf8 expression in tendons. |
Muscleless and aneural chick limb models, FGF4 bead implantation, in situ hybridization for tendon markers |
Developmental biology |
Medium |
12086472
|
| 2003 |
FGF4 acts paraculturally to maintain trophectoderm and primitive endoderm identity at E4.5; loss of zygotic FGF4 leads to failure of differentiation and function of extraembryonic cell types rather than a strictly mitogenic defect. |
Fgf4 null embryo analysis, in vitro culture experiments with FGF4 protein |
Genesis (New York, N.Y. : 2000) |
Medium |
12748966
|
| 2003 |
FGF-4 induces proliferation of cardiac cushion mesenchymal cells; FGF-4 protein localizes in cushion mesenchyme and activates FGFR2, and retroviral overexpression of FGF-4 in vivo expands cushion mesenchyme toward the lumen, promoting early valve leaflet formation. |
Immunolocalization, in situ hybridization for FGFRs, BrdU incorporation assay, retroviral FGF-4 overexpression in chick embryo, FGF-4 microinjection with BrdU |
Developmental biology |
Medium |
12798286
|
| 2004 |
Combined loss of Fgf4 and Fgf8 in the forelimb AER causes failure of limb bud mesenchyme survival and loss of Shh and Fgf10 expression, demonstrating that FGF4 functionally compensates for FGF8 in supporting limb mesenchyme viability. |
Double conditional knockout (Cre/loxP for Fgf4 and Fgf8), apoptosis analysis, in situ hybridization for Shh and Fgf10 |
Developmental biology |
High |
15328019
|
| 2004 |
HST-1/FGF-4 protects male germ cells from heat-stress-induced apoptosis by activating the MAPK survival cascade in germ cells and by stimulating lactate production from Sertoli cells, which is an indispensable nutrient for germ cell survival. |
Adenoviral FGF4 gene delivery to mouse testes, hyperthermia model, TUNEL apoptosis assay, MAPK activation by western blot, lactate production measurement |
Experimental cell research |
Medium |
14980503
|
| 2005 |
FGF4 can functionally replace FGF8 in limb skeletal development: when Fgf4 is expressed in place of Fgf8 via conditional allele switching, all Fgf8 inactivation-induced skeletal defects are rescued; excess FGF4 signaling causes polydactyly and syndactyly. |
Conditional Fgf4 gain-of-function allele activation simultaneous with Fgf8 inactivation via Cre recombinase, skeletal preparation analysis |
Development (Cambridge, England) |
High |
16308330
|
| 2010 |
The histone demethylase KDM7A (KIAA1718) directly activates FGF4 transcription by removing repressive H3K9me2 and H3K27me2 marks at the FGF4 locus; knockdown of KDM7A blocks neural differentiation and this is rescued by wild-type but not catalytically inactive KDM7A; this pro-neural effect is mediated through FGF4. |
KDM7A knockdown in mouse ESCs, rescue with wild-type vs. catalytic mutant KDM7A, ChIP for histone marks at Fgf4 locus, neural differentiation assays |
Cell research |
High |
20084082
|
| 2012 |
Loss of both Fgf4 and Fgf8 during late gastrulation results in failure to maintain paraxial mesoderm progenitors in the epiblast/tailbud, causing severe vertebral/rib defects, loss of Wnt3a and Brachyury expression, and cessation of somitogenesis after ~15–20 somites. |
Double conditional knockout (Cre/loxP) for Fgf4 and Fgf8, skeletal preparation, in situ hybridization for Wnt3a, Brachyury, and Notch pathway genes, BrdU/apoptosis analysis |
Developmental biology |
High |
22954964
|
| 2013 |
ARTD1/PARP1 PARylates Sox2, promoting Sox2 binding to the FGF4 enhancer and activating FGF4 expression during early reprogramming; exogenous FGF4 restores reprogramming capacity of Artd1-/- fibroblasts to wild-type levels, placing FGF4 downstream of ARTD1-Sox2 in the reprogramming pathway. |
Artd1 knockout fibroblasts, ARTD1 inhibitor treatment, ChIP for Sox2 at Fgf4 enhancer, exogenous FGF4 rescue of reprogramming efficiency |
Stem cells (Dayton, Ohio) |
High |
23939864
|
| 2013 |
FGF4 is the major limiting FGF in the preimplantation embryo controlling the ratio of primitive endoderm (PE) to epiblast (EPI) in the ICM; titrated exogenous FGF4 progressively increases PE proportions in a dose-dependent manner regardless of embryo genotype. |
Fgf4 hypomorphic/null mutant embryo series, exogenous FGF4 dose-response treatment, lineage marker analysis (GATA6/Nanog immunofluorescence) |
Developmental biology |
High |
24063807
|
| 2017 |
FGF4 signaling (via FGFR and ERK) is required for primitive endoderm specification in the ICM; Klf5 acts as an upstream repressor of Fgf4, as Klf5 knockout embryos show markedly upregulated Fgf4 and skewed PE specification, which is reversed by FGFR/ERK inhibitors. |
Klf5 knockout embryo analysis, FGFR/ERK inhibitor treatment, immunofluorescence for PE/EPI markers, Klf5 overexpression embryos |
Development (Cambridge, England) |
High |
28870993
|
| 2017 |
O-GlcNAcylation of PKCζ at its phosphorylation site inhibits PKCζ activation and consequently suppresses the FGF4-PKCζ-MEK-ERK1/2 signaling pathway in mouse embryonic stem cells, maintaining the undifferentiated state. |
O-GlcNAc inhibitor/enhancer treatment in ESCs, PKCζ mutagenesis, MEK/ERK phosphorylation western blot, FGF4 stimulation assays |
Stem cell reports |
Medium |
29249667
|
| 2018 |
Sox2 expression level (more than Oct4) drives synergistic binding to the Fgf4 Sox/Oct composite motif; quantitative fluorescence correlation spectroscopy shows that binding affinity of Oct4/Sox2 heterodimer to the Fgf4 regulatory element is primarily determined by the Sox2 concentration, explaining how Sox2 fluctuations control epiblast/PE lineage segregation via FGF4. |
Fluorescence correlation spectroscopy (FCS) binding affinity measurements for Oct4 and Sox2 on Fgf4 Sox/Oct motif |
The Biochemical journal |
Medium |
29487166
|
| 2021 |
FGF4 acts as a short-range paracrine signal mediating cell-cell communication that generates and maintains robust proportions of epiblast-like and primitive endoderm-like cells in mouse ESC cultures; FGF4 signaling enables autonomous re-establishment of cell-type proportions after perturbation. |
ESC culture with FGF4 signaling manipulation, cell-type proportion quantification, mathematical modeling, perturbation-restoration experiments |
Development (Cambridge, England) |
Medium |
34651174
|
| 2022 |
FGF4 protects the liver from NAFLD by activating hepatic FGFR4, which triggers a Ca2+/CaMKKβ-dependent AMPK-Caspase 6 signaling axis, leading to enhanced fatty acid oxidation and reduced hepatocellular apoptosis; hepatic Fgf4 deletion aggravates steatosis. |
Hepatic Fgf4 knockout mouse, recombinant FGF4 pharmacological treatment, FGFR4 blocking, AMPK and Caspase 6 pathway analysis, dietary NAFLD/NASH models |
Hepatology (Baltimore, Md.) |
High |
35152446
|
| 2023 |
FGF4 inhibits hepatocyte ferroptosis in autoimmune hepatitis by upregulating CISD3 and activating Nrf2/HO-1 signaling; Fgf4 depletion increases lipid peroxidation and iron accumulation, while recombinant FGF4 rescues ferroptotic markers (xCT, GPX4) in an erastin-induced model. |
Hepatic Fgf4 knockout mouse, recombinant FGF4 treatment, CISD3 overexpression/knockdown, Erastin-induced ferroptosis model in AML12 cells, TUNEL/lipid peroxidation assays |
International immunopharmacology |
Medium |
36702076
|
| 2024 |
Hepatic FGF4 is a direct transcriptional target of FXR that acts as a paracrine signal to downregulate bile acid synthesis genes Cyp7a1 and Cyp8b1 via an intracellular FGFR4-LRH-1 signaling node; this pathway functions upstream of the peripheral FXR-FGF15/19 pathway as a first-line checkpoint for intrahepatic bile acid homeostasis. |
Hepatic Fgf4 conditional knockout, FXR chromatin immunoprecipitation, FGFR4 signaling analysis, LRH-1 pathway analysis, cholestatic mouse models, recombinant FGF4 treatment |
Cell metabolism |
High |
39393353
|